Anti-rat Ig HRP detection kit from BD Biosciences Pharmingen
Agarose, high gelling temperature, Molecular Biology Grade from Research Organics, Inc.
Rabbit Anti-Human Q96IR3 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Agarose, high EEO, Molecular Biology Grade from Research Organics, Inc.
Biology Products:(Date:11/23/2009)...d strain of the deadly superbug MRSAan infection-c...csposes a far greater health threat than previousl...rding to a study in the December issue of Emergin...ily picked up in fitness centers, schools, and oth...den of MRSA within hospitals, the report found. ,...
(Date:11/23/2009)...f day matters to forest trees dealing with drought...team led by Professor Malcolm Campbell, University...rch and colleagues in the department of cell and s...italizing on their previous work to decode the gen... how poplar trees use their 45,000 genes to respon...
(Date:11/23/2009)...nts gathered this week for the seventh annual Nati... This year,s topic, "Synthetic Biology," brought t...hers to explore the engineering, scientific, and s...thetic biology. , Bonnie L. Bassler, professor o...is year,s conference chair, challenged the attende...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2WaferGen Closes on Private Financings of Approx 246 2 Million 13975 1WaferGen Closes on Private Financings of Approx 246 2 Million 13975 2WaferGen Closes on Private Financings of Approx 246 2 Million 13975 3Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin 28R 29 28MP 376 29 Treatment in Cystic Fibrosis Patients 13973 1Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin 28R 29 28MP 376 29 Treatment in Cystic Fibrosis Patients 13973 2Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin 28R 29 28MP 376 29 Treatment in Cystic Fibrosis Patients 13973 3Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin 28R 29 28MP 376 29 Treatment in Cystic Fibrosis Patients 13973 4ABRISA Appoints Jim Veler as President CEO 13971 1ABRISA Appoints Jim Veler as President CEO 13971 2ABRISA Appoints Jim Veler as President CEO 13971 3(Date:11/24/2009)...vember 24 Shire plc (LSE...harmaceutical company, today,announced that it has...for,velaglucerase alfa, the company,s enzyme repla... Type 1 Gaucher disease. This is the third marketi...n submitted, with previous,submissions in the Unit...
(Date:11/24/2009)... Calif., Nov. 24 Genomic...t Randy Scott, Genomic Health,s Executive Chairman...alth Care Conference in New York City on Tuesday, ...s the live and subsequently archived webcast of th...on of Genomic Health,s website at http://investor...
(Date:11/24/2009)...rogram Connects Customers with Partners Validated ...Genotek Products , Ottawa... leading provider of products for biological sampl... announced its new global partner program. The pro...ek,s partner community and is designed to help par...
(Date:11/24/2009)...v. 24 Cell Therapeutics,... present at the 21st Annual Piper Jaffray Health C...er 1-2, 2009, at the New York Palace Hotel. ,... a.m. Eastern Time in Holmes 1 (4th Floor). A live...able at www.celltherapeutics.com , and it will al...
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3